+499.5%
MRNA vs OMC
+9.8%
+489.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | OMC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.5% | +0.3% | -1.0% |
| 7D | +5.5% | -6.4% | +11.9% | +8.9% |
| 30D | +158.7% | +1.1% | +157.6% | +159.8% |
| 3M | +182.1% | +10.4% | +171.7% | +172.1% |
| 6M | +151.8% | -1.7% | +153.5% | +154.9% |
| YTD | +393.6% | +4.4% | +389.1% | +383.9% |
| 1Y | +499.5% | +8.4% | +491.0% | +461.8% |
| All | +499.5% | +9.8% | +489.7% | +461.8% |
Cumulative growth
Daily Returns
Daily percentage return beside OMC.
Daily Out/Under-Performance
Portfolio return minus OMC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × OMC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded OMC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling